The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
FDA is proposing to end the use of oral phenylephrine as an active ingredient from OTC Monograph M012 for the temporary relief of nasal congestion because the agency determined it is not effective.
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Vytvořte si vlastní zdroj
Jste připraveni to vyzkoušet?
Spusťte 14denní zkušební verzi bez nutnosti platební karty.